期刊文献+

血尿酸水平与帕金森病83例临床分期分型的关系 被引量:4

下载PDF
导出
摘要 目的:对帕金森病患者血尿酸水平进行分析,探讨其与帕金森病临床分期分型关系。方法:帕金森病83例测定UPDRSⅢ量表,行Hoehn-Yahr分期,根据Schrag法行临床分型;同时收集匹配的同期健康体检者为对照组。两组均测定空腹静脉血尿酸值并行统计学分析。结果:(1)血尿酸水平比较:PD组264±83μmol.L-1明显低于对照组341±69μmol.L-1(P<0.01)。(2)PD组不同临床分期血尿酸:Ⅰ+Ⅱ期32例262±76μmol.L-1,Ⅲ期276±87μmol.L-1,Ⅳ+Ⅴ期24例268±71μmol.L-1与对照组血尿酸水平比较差异有统计学意义(P<0.05)。(3)PD组不同临床分型血尿酸:震颤型34例272±68μmol.L-1,强直型28例258±74μmol.L-1,混合型21例265±81μmol.L-1与对照组血尿酸水平比较差异有统计学意义(P<0.05)。结论:血尿酸水平降低可能是帕金森病危险因素之一,可作为帕金森病早期的生物学标志之一,但与疾病临床特征无关。
作者 汪跃春
出处 《交通医学》 2011年第3期305-306,共2页 Medical Journal of Communications
  • 相关文献

参考文献7

  • 1Schrag A,Jahanshahi M,Quinn N. What contributes to quality of life in patients with Parkinson's disease[J]?J Neurol Neu- rosurg Psychiatry,2000,69(3):308-312.
  • 2Weisskopf MG,O'Reilly E,Chen H,et al.Plasma urate and risk of Parkinson's disease[J].Am J Epidemiol,2007,166(5): 561-567.
  • 3De Lau LM,Koudstaal PJ,Hofman A,et al.Serum uric acid levels and the risk of Parkinson disease[J].Ann Neurol, 2005,85(5):797-800.
  • 4Church WH,Ward VL.Uric acid is reduced in the substantia nigra in Parkinson's disease:effect on dopamine oxidation[J]. Brain Res Bull, 1994,33 (4) :419-425.
  • 5Guerreiro S,Ponceau A,Toulorge D,et al.Protection of mid- brain dopaminergic neurons by the end-product of purine metabolism uric acid:potentiation by low-level depolarization [J].J Neurochem,2009,109(4):1118-1128.
  • 6Annanmaki T, Pessale DA,Hokkanen L,et al.Uric acid asso- ciated with cognition in Parkinson's disease[J].Parkinsonism Relat Disord,2008,14 (23) :576-578.
  • 7李丹,王晓君,罗蔚锋,朱婷鸽,胡伟东,毛成洁,刘春风.尿酸对帕金森病患者不同认知功能域影响分析[J].中华神经科杂志,2010,43(6):400-402. 被引量:15

二级参考文献19

  • 1Hughes TA,Ross HF,Musa S,et al.A 10-year study of the incidence of and factors predicting dementia in Parkinson ' s disease.Neurology,2000,54:1596-1602.
  • 2Emre M.Dementia associated with Parkinson' s disease.Lancet Neurol,2003,2:229-237.
  • 3de Lau LM,Koudstaal PJ,Hofman A,et al.Serum uric acid levels and the risk of Parkinson disease.Ann Neurol,2005,58:797-800.
  • 4Annanmaki T,Muuronen A,Murros K.Low plasma uric acid level in Parkinson' disease.Mov Disord,2007,22:1133-1137.
  • 5Meara J,Bhowmick BK,Hobson P.Accuracy of diagnosis in patients with presumed Parkinson' s disease.Age Ageing,1999,28:99-102.
  • 6Nazem S,Siderowf AD,Duda JE,et al.Montreal cognitive assessment performance in patients with Parkinson' s disease with " normal " global cognition according to mini-mental state examination score.J Am Geriatr Soc,2009,57:304-308.
  • 7Ismail Z,Rajji TK,Shulman KI.Brief cognitive screening instruments:an update.Int J Geriatr Psychiatry,2010,25:111-120.
  • 8Zgaljardic DJ,Borod JC,Foldi NS,et al.A review of the cognitive and behavioral sequelae of Parkinson ' s disease:relationship to frontostriatal circuitry.Cogn Behav Neurol,2003,16:193-210.
  • 9de la Monte SM,Canju N,Feroz N,et al.Oxygen free radical injury is sufficient to cause some Alzheimer-type molecular abnormalities in human CNS neuronal cells.J Alzheimers Dis,2000,2:261-281.
  • 10Maiese K,Chong ZZ.Insights into oxidative and potential novel therapeutic targets for Alzhermer disease.Restor Neurol Neurosci,2004,22:87-104.

共引文献14

同被引文献29

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部